NCT00252811View on ClinicalTrials.gov

A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

PHASE2WithdrawnINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

February 29, 2004

Conditions

Breast Cancer

Interventions

DRUG

Gefitinib

Trial Locations (1)

Unknown

Research Site, Milan

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY